EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Gut Microbiota in Colorectal Cancer: Biological Role and Therapeutic Opportunities

Himani Pandey, Daryl W T Tang iD, Sunny H Wong iD, Devi Lal iD

Cancers · 30.01.2023 · 15 (3) · 866

DOI: 10.3390/cancers15030866 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 30.01.2023. Verfasst von Himani Pandey und 3 weiteren Autor:innen. Beteiligte Einrichtung: Redcliffe Labs, Electronic City, Noida 201301, India. Die Arbeit wurde bisher 162-mal zitiert (Crossref) und nennt 591 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NTU Start Up Grant and Wang Lee Wah Memorial Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Colorectal cancer (CRC) is the second-leading cause of cancer-related deaths worldwide. While CRC is thought to be an interplay between genetic and environmental factors, several lines of evidence suggest the involvement of gut microbiota in promoting inflammation and tumor progression. Gut microbiota refer to the ~40 trillion microorganisms that inhabit the human gut. Advances in next-generation sequencing technologies and metagenomics have provided new insights into the gut microbial ecology and have helped in linking gut microbiota to CRC. Many studies carried out in humans and animal models have emphasized the role of certain gut bacteria, such as Fusobacterium nucleatum, enterotoxigenic Bacteroides fragilis, and colibactin-producing Escherichia coli, in the onset and progression of CRC. Metagenomic studies have opened up new avenues for the application of gut microbiota in the diagnosis, prevention, and treatment of CRC. This review article summarizes the role of gut microbiota in CRC development and its use as a biomarker to predict the disease and its potential therapeutic applications.

Schlagwörter

Stichwörter der Autor:innen

chemotherapycolorectal cancerdysbiosisimmunotherapymicrobiotaprobiotics

Autor:innen und Institutionen

  • Redcliffe Labs, Electronic City, Noida 201301, India.
  • School of Biological Sciences, Nanyang Technological University, Singapore 308232, Singapore.
  • Centre for Microbiome Medicine, Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore 308232, Singapore.
  • Department of Zoology, Ramjas College, University of Delhi, Delhi 110007, India.

ORCID-Profile: Daryl W T Tang, Sunny H Wong, Devi Lal

Förderung

  • NTU Start Up Grant and Wang Lee Wah Memorial Fund

Zitieren

APA

Pandey, H., Tang, D. W. T., Wong, S. H., & Lal, D. (2023). Gut Microbiota in Colorectal Cancer: Biological Role and Therapeutic Opportunities. Cancers, 15(3), 866. https://doi.org/10.3390/cancers15030866

Vancouver

Pandey H, Tang DWT, Wong SH, Lal D. Gut Microbiota in Colorectal Cancer: Biological Role and Therapeutic Opportunities. Cancers. 2023;15(3):866. doi:10.3390/cancers15030866

BibTeX
@article{Pandey2023,
  author = {Pandey, Himani and Tang, Daryl W T and Wong, Sunny H and Lal, Devi},
  title = {Gut Microbiota in Colorectal Cancer: Biological Role and Therapeutic Opportunities},
  journal = {Cancers},
  year = {2023},
  volume = {15},
  number = {3},
  pages = {866},
  doi = {10.3390/cancers15030866}
}
Kostenlos starten →